In addition, hepatocyte-specific deletion or pharmaceutical inhibition of toll-like receptor 4 (TLR4), a master regulator of cellular inflammation to which LPS binds, attenuates liver injury following sepsis (Deng et al., 2013; Engelmann et al., 2020). The gene discussed is TLR4; the disease is Sepsis.